Latest filing published 09 Mar 2026 for Teva Pharmaceutical Industries Ltd, €471k.
Filing timeline
BuySaleInsider track record
Matthew Shields: trading record in brief
This profile gathers the share dealings of Matthew Shields in Teva Pharmaceutical Industries Ltd. Between 3 June 2025 and 5 March 2026, the trades on record add up to 4 filings.
The open-market record consists of 2 sales worth €564k, with no purchase. The rest of the record consists of 2 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
On 9 March 2026 came the latest disclosure, an open-market sale for €471k in Teva Pharmaceutical Industries Ltd. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Matthew Shields
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 17,295 shares@ US$31.6736.1% of flowOrdinary SharesSEC:0001193125-26-098473:1
- 17,295 sharesOrdinary SharesSEC:0001193125-26-098473:0
- 6,206 shares@ US$17.027.1% of flowOrdinary SharesSEC:0000950170-25-082498:1
- 16,195 sharesOrdinary SharesSEC:0000950170-25-082498:0
4 of 4 declarations
